Osteopontin associated Bifidobacterium bifidum microencapsulation modulates infant fecal fermentation and gut microbiota development.

Autor: Huang Y; South China University of Technology, School of Food Science and Engineering, Overseas Expertise Introduction Center for Discipline Innovation of Food Nutrition and Human Health, Guangzhou 510640, China., Lu Z; H&H Group, H&H Research, China Research and Innovation Center, Guangzhou 510700, China., Liu F; H&H Group, H&H Research, China Research and Innovation Center, Guangzhou 510700, China., Lane JA; H&H Group, H&H Research, Global Research and Technology Center, P61 K202 Co. Cork, Ireland., Chen J; H&H Group, H&H Research, China Research and Innovation Center, Guangzhou 510700, China., Huang Q; South China University of Technology, School of Food Science and Engineering, Overseas Expertise Introduction Center for Discipline Innovation of Food Nutrition and Human Health, Guangzhou 510640, China., Hu R; H&H Group, H&H Research, China Research and Innovation Center, Guangzhou 510700, China. Electronic address: will.hu@hh.global., Zhang B; South China University of Technology, School of Food Science and Engineering, Overseas Expertise Introduction Center for Discipline Innovation of Food Nutrition and Human Health, Guangzhou 510640, China; Sino-Singapore International Research Institute, Guangzhou 510555, China. Electronic address: zhangb@scut.edu.cn.

Publikováno v: Food research international (Ottawa, Ont.) [Food Res Int] 2024 Dec; Vol. 197 (Pt 1), pp. 115211. Date of Electronic Publication: 2024 Oct 22.

Preparing for responsive management versus preparing for renal dialysis in multimorbid older people with advanced chronic kidney disease (Prepare for Kidney Care): Study protocol for a randomised controlled trial.

Autor: Worthington J; Bristol Trials Centre, Bristol Medical School, University of Bristol, 1-5 Whiteladies Road, Bristol, BS8 1NU, UK., Soundy A; Bristol Trials Centre, Bristol Medical School, University of Bristol, 1-5 Whiteladies Road, Bristol, BS8 1NU, UK., Frost J; Bristol Trials Centre, Bristol Medical School, University of Bristol, 1-5 Whiteladies Road, Bristol, BS8 1NU, UK., Rooshenas L; Population Health Sciences, Bristol Medical School, University of Bristol, Canynge Hall, 39 Whatley Road, Bristol, BS8 2PS, UK., MacNeill SJ; Bristol Trials Centre, Bristol Medical School, University of Bristol, 1-5 Whiteladies Road, Bristol, BS8 1NU, UK., Realpe Rojas A; Population Health Sciences, Bristol Medical School, University of Bristol, Canynge Hall, 39 Whatley Road, Bristol, BS8 2PS, UK., Garfield K; Bristol Trials Centre, Bristol Medical School, University of Bristol, 1-5 Whiteladies Road, Bristol, BS8 1NU, UK., Liu Y; Bristol Trials Centre, Bristol Medical School, University of Bristol, 1-5 Whiteladies Road, Bristol, BS8 1NU, UK., Alloway K; North Bristol NHS Trust, Southmead Hospital, Bristol, BS10 5NB, UK., Ben-Shlomo Y; Population Health Sciences, Bristol Medical School, University of Bristol, Canynge Hall, 39 Whatley Road, Bristol, BS8 2PS, UK., Burns A; UCL Department of Nephrology, Royal Free Hospital, University College, London, NW3 2QG, UK., Chilcot J; Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, WC2R 2LS, UK., Darling J; Public and Patient Involvement Representative, London, UK., Davies S; Institute for Science and Technology in Medicine, Keele University, Keele, ST5 5BG, UK., Farrington K; Renal Unit, East and North Hertfordshire NHS Trust, Coreys Mill Lane, Stevenage, SG1 4AB, UK., Gibson A; ARC West, Whitefriars, Lewins Mead, Bristol, BS1 2NT, UK., Husbands S; Population Health Sciences, Bristol Medical School, University of Bristol, Canynge Hall, 39 Whatley Road, Bristol, BS8 2PS, UK., Huxtable R; Population Health Sciences, Bristol Medical School, University of Bristol, Canynge Hall, 39 Whatley Road, Bristol, BS8 2PS, UK., McNally H; North Bristol NHS Trust, Southmead Hospital, Bristol, BS10 5NB, UK., Murphy E; Centre for Care Excellence, Coventry University and University Hospitals Coventry and Warwickshire NHS Trust, Coventry, UK.; Institute for Cardio-Metabolic Medicine, University Hospitals Coventry and Warwickshire NHS Trust, Coventry, UK., Murtagh FEM; Wolfson Palliative Care Research Centre, Hull York Medical School, University of Hull, Hull, HU6 7RX, UK., Rayner H; Renal Unit, Birmingham Heartlands Hospital, Bordesley Green E, Birmingham, B9 5SS, UK., Rice CT; Bristol Trials Centre, Bristol Medical School, University of Bristol, 1-5 Whiteladies Road, Bristol, BS8 1NU, UK., Roderick P; Faculty of Medicine, University of Southampton, University Road, Southampton, SO17 1BJ, UK., Salisbury C; Population Health Sciences, Bristol Medical School, University of Bristol, Canynge Hall, 39 Whatley Road, Bristol, BS8 2PS, UK., Taylor J; Bristol Trials Centre, Bristol Medical School, University of Bristol, 1-5 Whiteladies Road, Bristol, BS8 1NU, UK., Winton H; Bristol Trials Centre, Bristol Medical School, University of Bristol, 1-5 Whiteladies Road, Bristol, BS8 1NU, UK., Donovan J; Population Health Sciences, Bristol Medical School, University of Bristol, Canynge Hall, 39 Whatley Road, Bristol, BS8 2PS, UK., Coast J; Population Health Sciences, Bristol Medical School, University of Bristol, Canynge Hall, 39 Whatley Road, Bristol, BS8 2PS, UK., Lane JA; Bristol Trials Centre, Bristol Medical School, University of Bristol, 1-5 Whiteladies Road, Bristol, BS8 1NU, UK., Caskey FJ; Population Health Sciences, Bristol Medical School, University of Bristol, Canynge Hall, 39 Whatley Road, Bristol, BS8 2PS, UK. Fergus.caskey@bristol.ac.uk.; North Bristol NHS Trust, Southmead Hospital, Bristol, BS10 5NB, UK. Fergus.caskey@bristol.ac.uk.

Publikováno v: Trials [Trials] 2024 Oct 17; Vol. 25 (1), pp. 688. Date of Electronic Publication: 2024 Oct 17.

Infant Milk Formula Enriched in Dairy Cream Brings Its Digestibility Closer to Human Milk and Supports Intestinal Health in Pre-Clinical Studies.

Autor: Kondrashina A; Health and Happiness (H&H) Group, H&H Research, Global Research and Technology Centre, Fermoy, P61 K202 Co. Cork, Ireland., Mamone G; Institute of Food Science, National Research Council, 83100 Avellino, Italy., Giblin L; Teagasc Food Research Centre, Moorepark, Fermoy, P61 P302 Co. Cork, Ireland., Lane JA; Health and Happiness (H&H) Group, H&H Research, Global Research and Technology Centre, Fermoy, P61 K202 Co. Cork, Ireland.

Publikováno v: Nutrients [Nutrients] 2024 Sep 11; Vol. 16 (18). Date of Electronic Publication: 2024 Sep 11.

Prostate-Specific Antigen Screening and 15-Year Prostate Cancer Mortality: A Secondary Analysis of the CAP Randomized Clinical Trial.

Autor: Martin RM; Department of Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, United Kingdom.; National Institute for Health Research Bristol Biomedical Research Centre, University Hospitals Bristol and Weston NHS Foundation Trust and University of Bristol, Bristol, United Kingdom.; MRC Integrative Epidemiology Unit, University of Bristol, Bristol, United Kingdom., Turner EL; Department of Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, United Kingdom., Young GJ; Department of Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, United Kingdom., Metcalfe C; Department of Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, United Kingdom., Walsh EI; Department of Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, United Kingdom., Lane JA; Department of Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, United Kingdom., Sterne JAC; Department of Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, United Kingdom.; National Institute for Health Research Bristol Biomedical Research Centre, University Hospitals Bristol and Weston NHS Foundation Trust and University of Bristol, Bristol, United Kingdom.; Health Data Research UK South-West, University of Bristol, Bristol, United Kingdom., Noble S; Department of Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, United Kingdom., Holding P; Nuffield Department of Surgical Sciences, University of Oxford, Oxford, United Kingdom., Ben-Shlomo Y; Department of Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, United Kingdom., Williams NJ; Department of Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, United Kingdom., Pashayan N; Department of Applied Health Research, University College London, London, United Kingdom., Bui MN; Department of Applied Health Research, University College London, London, United Kingdom., Albertsen PC; Division of Urology, University of Connecticut Health Center, Farmington., Seibert TM; Department of Radiation Medicine and Applied Sciences, University of California San Diego, La Jolla.; Department of Radiology, University of California San Diego, La Jolla.; Department of Bioengineering, University of California San Diego, La Jolla., Zietman AL; Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston., Oxley J; Department of Cellular Pathology, North Bristol NHS Trust, Bristol, United Kingdom., Adolfsson J; Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden., Mason MD; School of Medicine, Cardiff University, Cardiff, Wales, United Kingdom., Davey Smith G; Department of Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, United Kingdom.; MRC Integrative Epidemiology Unit, University of Bristol, Bristol, United Kingdom., Neal DE; Nuffield Department of Surgical Sciences, University of Oxford, Oxford, United Kingdom., Hamdy FC; Nuffield Department of Surgical Sciences, University of Oxford, Oxford, United Kingdom., Donovan JL; Department of Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, United Kingdom.

Publikováno v: JAMA [JAMA] 2024 May 07; Vol. 331 (17), pp. 1460-1470.

Fifteen-year outcomes after monitoring, surgery, or radiotherapy for prostate cancer

Autor: Hamdy, FC, Donovan, JL, Lane, JA, Metcalfe, C, Davis, M, Turner, EL, Martin, RM, Young, GJ, Walsh, EI, Bryant, RJ, Bollina, P, Doble, A, Doherty, A, Gillatt, D, Gnanapragasam, V, Hughes, O, Kockelbergh, R, Kynaston, H, Paul, A, Paez, E, Powell, P, Rosario, DJ, Rowe, E, Mason, M, Catto, JWF, Peters, TJ, Oxley, J, Williams, NJ, Staffurth, J, Neal, DE

Publikováno v: Donovan, J L, Lane, J A, Metcalfe, C, Davis, M J, Turner, E L, Martin, R M, Walsh, E I, Peters, TJ & Williams, N J 2023, ' Fifteen-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Prostate Cancer ', New England Journal of Medicine, vol. 388, no. 17, pp. 1547-1558 . https://doi.org/10.1056/NEJMoa2214122

BACKGROUND: Between 1999 and 2009 in the United Kingdom, 82,429 men between 50 and 69 years of age received a prostate-specific antigen (PSA) test. Localized prostate cancer was diagnosed in 2664 men. Of these men, 1643 were enrolled in a trial to ev

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a1e71e92ec9ee7e8fc17a27d17b70fd8
https://ora.ox.ac.uk/objects/uuid:b3f24670-b965-4fd7-abb4-5939ae7b7b12